DOW JONES21,636.78-915.39 -4.06%
S&P 5002,541.47-88.60 -3.37%
NASDAQ7,502.38-295.16 -3.79%

H.C. Wainwright Maintains Neutral on Sage Therapeutics, Lowers Price Target to $78

H.C. Wainwright maintains Sage Therapeutics (NASDAQ:SAGE) with a Neutral and lowers the price target from $87 to $78.

Benzinga · 02/28/2020 12:35

H.C. Wainwright maintains Sage Therapeutics (NASDAQ:SAGE) with a Neutral and lowers the price target from $87 to $78.